The RBE-weighted absorbed dose, called "biological dose," has been routinely used for carbon-ion treatment planning in Japan to formulate dose prescriptions for treatment protocols. This paper presents a microdosimetric approach to measuring the biological dose, which was redefined to be derived from microdosimetric quantities measured by a tissue-equivalent proportional counter (TEPC). The TEPC was calibrated in 60 Co gamma rays to assure a traceability of the TEPC measurement to Japanese standards and to eliminate the discrepancies among matching counters. The absorbed doses measured by the TEPC were reasonably coincident with those measured by a reference ionization chamber. The RBE value was calculated from the microdosimetric spectrum on the basis of the microdosimetric kinetic model. The biological doses obtained by the TEPC were compared with those prescribed in the carbon-ion treatment planning system. We found that it was reasonable for the measured biological doses to decrease with depth around the rear SOBP region because of beam divergence, scattering effect, and fragmentation reaction. These results demonstrate that the TEPC can be an effective tool to assure the radiation quality in carbon-ion radiotherapy.
INTRODUCTION
Heavy-ion beams have been used for the treatment of deeply seated cancer because of their potential for excellent dose distribution and their high relative biological effectiveness (RBE) around the Bragg peak. From the years 1977 to 1993, helium-, carbon-, neon-, silicon-, and argon-ion beams were applied as heavy-ion radiotherapy at the Lawrence Berkeley National Laboratory in the United States. 1) In 1994, routine carbon-ion radiotherapy was started using the Heavy Ion Medical Accelerator in Chiba (HIMAC) at the National Institute of Radiological Sciences (NIRS) in Japan.
2) As of 2008, more than 4,000 patients were enrolled in clinical trials using carbon-ion beams in the HIMAC. As a result of these trials, carbon-ion beam therapy has been clinically indicated to raise the cure rate of various types of tumor.
3) Carbon-ion radiotherapy has also been carried out since 1997 at the Gesellschaft für Schwerionenforschung mbH (GSI) in Germany 4) and since 2002 at the Hyogo Ion Beam Medical Center in Japan. 5) Currently, many carbonion treatment facilities are being built in various countries around the world.
For carbon-ion radiotherapy, it is essential to calculate not only the absorbed dose distribution but also the RBE distribution, because the RBE varies greatly depending on the depth of the target area in the patient's body. Currently, different methods are used to calculate the RBE-weighted absorbed dose in the carbon-ion treatment planning system (TPS) in Germany 6) and Japan. 7, 8) In Japan, different RBE values are used for clinical and biological endpoints. The "biological RBE" was defined at the 10% surviving fraction of in-vitro human salivary gland (HSG) tumor cells. The "clinical RBE" was assumed to be proportional to the "biological RBE", and it was determined to be 3.0 at the neutron-equivalent position of the carbon spread-out Bragg peak (SOBP). 9) At NIRS, the "bioloical dose" was defined as the product of the "biological RBE" and the absorbed dose. The "clinical dose" was defined as the "biological dose" multiplied by the common factor derived from the ratio of the "clinical RBE" and the "biological RBE" at the neutron equivalent point. Medical doctors determine the irradiation plan based on the clinical dose distribution on a patient's computed tomography (CT) image. Although the NIRS-defined clinical dose has not yet been internationally recognized, it has been essential for assigning a prescribed dose and analyzing the clinical results of tumor control and normal tissue complication at NIRS. 10, 11) In the future, a uniform specification of the biologically weighted dose will be required for the use of carbon-ion radiotherapy to increase worldwide with quality assurance (QA).
In neutron therapy, the microdosimetric approach 12) was successfully adapted to search for a characterization of the radiation quality that agreed well with the biological observations.
13) The microdosimetric kinetic model (MKM) 14) was shown to be useful for calculating the survival curves of HSG tumor cells in response to treatment with monoenergetic heavy-ion beams. 15) The MKM was modified to estimate the survival curve from the microdosimetric spectra measured using a tissue-equivalent proportional counter (TEPC).
16) The same type of the TEPC was used to measure the relative biologically weighted dose and compare with Monte Carlo simulations for carbon-ion beams at HIMAC. 17, 18) However, the absolute value of the clinically relevant dose has not been evaluated by the TEPC.
The purpose of this study was to derive the absolute biological dose from measurable quantities for carbon-ion treatment beams. The absolute absorbed dose was measured using the TEPC independent of a reference ionization chamber to obtain the biological dose in one step. Then, the biological dose distribution measured by the TEPC was compared with the TPS. This system makes it possible to investigate the biological dose distributions for particle beam therapy under various irradiation conditions. We expect that the TEPC measurement will be a useful tool for quality assurance of the biological doses in particle beam therapy.
MATERIALS AND METHODS

Microdosimetric measurement
The microdosimetric spectra were measured using a type of proportional counter (LET-1/2; Far West Technology, Inc.). The sensitive volume of the counter was nominally a sphere of 12.7-mm diameter, around which a spherical wall of A-150 tissue-equivalent plastic (thickness: 1.27 mm) was situated. The wall was housed in an aluminum shell (thickness: 0.178 mm) to maintain a proportional gas under low pressure. The propane-based tissue-equivalent gas (p-TEG; 54.6% C3H8, 40.16% CO2, and 5.26% N2, by volume) was enclosed with the pressure of 4.4 kPa in the counter to simulate the energy imparted to a spherical tissue with a unit density of 1.0-μm diameter. The TEPC was operated with a voltage bias of + 640 V. The electric impulse from the counter entered a pre-amplifier (preamplifier 142B; ORTEC), and then the pre-amplified output signal was divided to enter three linear amplifiers of 2, 30, and 450 gains (amplifier 572/671; ORTEC) to realize a wide measurement range and fine energy resolution. These signals were stored in multichannel analyzers (MCA8000A; AMPTEK). A calibration pulser was used to examine the linearity between the pulse height of the preamplifier output and the channel and to relate those channels of the three spectra.
The TEPC incorporated a gravity-operated 244 Cm alpha source that was designed to be positioned so that the 244 Cm alpha particles passed through the spherical diameter of the sensitive volume. In this study, the internal source was used only to assure the reproducibility of the spectra measured by the TEPC in consideration of the uncertainties about the poor alignment of the internal alpha sources.
19) The internal 244 Cm calibration cannot ensure the uniformity of energy imparted to various TEPCs for the same radiation field, because it is impossible to eliminate the uncertainty in the internal geometry of the TEPC. To address this problem, we calibrated the absolute pulse-height of the TEPC by external 60 Co gamma rays whose radiation quality has been well known as a reference beam for calibration of absolute dosimetry. The 60 Co calibration can reduce uncertainties about correction factors of beam quality and geometrical uncertainty in the internal structure of the TEPC, and it can allow the development of a traceability of microdosimetric measurements for various TEPCs. Moreover, the TEPC dosimetry may be efficient for deriving a more accurate absorbed dose that takes the energy dependence of the event by event stopping power ratio and w value into account. 60 
Calibration of the TEPC with
Co gamma rays
The absorbed dose of the TEPC was calibrated in 60 Co gamma rays with an ionization chamber (model C-110 600 ml; Applied Engineering, Inc., Japan) that had been calibrated with the calibration factor in terms of exposure for 60 Co gamma rays at the Japanese primary standard dosimetry laboratory (PSDL). The ionization chamber had a wall of 0.5 g/cm 2 to establish the transient charged-particle equilibrium at its center. The center of the ionization chamber was placed 7.470 m from the 60 Co source. The exposure rate measured by the ionization chamber was 15.05 nC kg -1 sec -1 . The TEPC was placed at the same calibration point. A buildup cap made of polymethylmethacrylate, whose thickness was 2.8 mm, was put on the aluminum shell of the TEPC so that the total water-equivalent thickness of the wall, the aluminum shell, and the buildup cap was equal to the wall thickness of the ionization chamber, that is, 0.5 g/cm 2 . Each measurement for the calibration was repeated more than five times to observe the variation in the results. The mean count rate of the TEPC was about 1139 cps. The mean total count was 209613 ± 3289 counts, including the timer end effect with the setting time of 3 minutes.
The absorbed dose to tissue-equivalent gas in the TEPC, D gas , was calculated from the exposure, X, as follows: 20, 21) ,
where is the mean energy of 33.97 eV required to form an ion pair in air per electron charge, 22) A wall is the correction factor for photon attenuation in the wall and the buildup cap, β wall is the quotient of absorbed dose by the collision part of kerma, and K m is a correction factor for material nonequivalence of the wall, shell, buildup cap, and air for the gas. The A wall value was calculated to be 0.985 from the averaged mass energy absorption coefficient and the water-equivalent thickness of the wall, shell, and cap. The βwall value was assumed to be 1.004 for the 60 Co gamma rays.
23) The Km value was calculated to be 1.135 according to the following equation: 24, 25) , (2) where is the ratio of the averaged restricted mass collision stopping power for material A to material B, is the ratio of the averaged mass energy absorption coefficient for material A to material B, a is the fraction of cavity air ionization owing to electrons arising in the wall, and τ is the fraction of cavity air ionization owing to electrons arising in the shell. The a and τ values were calculated by empirical equations.
26) The mass energy absorption coefficients taken from the IAEA TRS-381 26) and NIST databases.
27) The mass collision stopping powers for electrons, which had about half as much energy as 60 Co gamma ray energy, were substituted for the restricted mass collision stopping powers.
The absorbed dose to tissue-equivalent gas in the TEPC, Dgas, is also equal to the mean value of specific energy, which is obtained by the sum of the single-event specific energy, z1, as follows: ,
where hi is the quantity proportional to the pulse height in the i channel of the composite spectrum, ni is the count number in the i channel, and Ngas is the calibration factor to change the hi value into the single-event specific energy, z1i.
Since the Dgas value measured by the TEPC should be the same as that by the ionization chamber, the calibration factor, Ngas, was finally obtained as follows:
.
The output correction of room temperature and atmospheric pressure was unnecessary because the sensitive volume of the TEPC was hermetically sealed. Change in the gas-gain of the TEPC was relatively evaluated by the peak channel shift of the internal alpha spectrum. Though the alpha peak shift was found after the 60 Co calibration, its uncertainty was negligible because the h i value was normalized by the alpha peak channel.
The lineal energy, y, is theoretically proportional to the single-event specific energy, z 1 , and the proportional factor is the mass of interest divided by the mean cord length. However, measuring the actual values of the mass and mean cord length of the TEPC was so difficult that we decided to calibrate the y value independently of the z1 value. Simultaneously with the absorbed dose calibration, the y value was also calibrated with the dose-mean lineal energy, yD, for the 60 Co gamma rays. The yD value should be obtained from the 60 Co gamma ray spectra as follows: (5) where hi and ni are the same data as those in equation (3), and Ny is the calibration factor to change the hi value into the lineal energy, yi. The Ny value was determined so that the mean value of the yD values from the repetitive measurements was equal to 1.81 keV/μm for 60 Co gamma rays.
28)
The difference of yD value between the two calibrations with the external 60 Co source and the internal alpha source was not so significant for the one TEPC used in the previous study because the yD value for 60 Co gamma rays was calibrated to be 1.81 keV/μm as the same yD value in the TEPC measurement calibrated with the internal alpha source. 16) However, another TEPC calibrated with the internal alpha source resulted in about 13% larger yD values for the external 60 Co gamma rays and carbon-ion beams than the previous measurement. The reason of difference was thought to be caused by the poor alignment of the internal alpha source. Therefore, the 60 Co gamma-rays calibration was implemented to reproduce the previous TEPC measurement in order to apply the same MKM parameters for these TEPC measurements.
Irradiation system for carbon-ion radiotherapy
The HIMAC has ion sources, a radio frequency quadrupole linac, an Alvarez linac, and two synchrotrons. The flattop duration in a beam pulse is maintained at around 2 sec under an operation period of 3.3 sec to deliver carbon ions. Figure 1 shows the schematic layout of the irradiation system of therapeutic carbon-ion beams when the TEPC measurement was performed in the horizontal beam course. The carbon-ions were laterally broadened by a wobbler-scatterer system before entering the treatment room. 
the tantalum scatterer was set at 0.65 mm. The ridge filter used to make a SOBP beam was a stationary device that typically consists of about 40 aluminum ridge bars abreast, placed every 5 mm. Each ridge bar was designed to be the same stepwise shape so that HSG cells were uniformly killed in the SOBP region. The survival curves and RBE values in the SOBP beams were calculated from the experimental survival data for HSG cells as a function of the linear energy transfer (LET) of mono-energetic carbon-ion beams. At the NIRS, the clinical RBE value was assumed to be proportional to the 10% survival RBE of the HSG cells. The absolute clinical RBE distribution was determined to be 3.0 at the neutronequivalent position in the carbon-ion SOBP beam. The neutron-equivalent position was empirically designated as a SOBP beam depth of 80 keV/μm in dose-averaged LET.
9)
TEPC measurement for a carbon-ion beam
The beam condition for the TEPC measurement was a typical therapeutic carbon-ion beam with an initial kinetic energy of 290 MeV/u with a SOBP size of 6 cm and a field size of 10-cm diameter. The TEPC measurements were performed on the horizontal beam courses in the HIMAC. Microdosimetric spectra were measured by the TEPC at various depths in a water phantom. The beam intensity was reduced to about 2 × 10 5 particles/pulse by defocusing carbon-ions with electric magnets at the inlet of the linac or the synchrotron to eliminate the dead time of the TEPC measurement. The count rate was 10 4 counts/pulse at maximum in the sensitive volume of the TEPC. The radiation quality of the low-intensity beam was thought to be the same as that of the usual beam intensity (2 × 10 9 particles/pulse). In the treatment room, the parallel-plate ionization chamber (diameter: 220 mm, gap: 5 mm) has worked as the main monitor to define the monitor unit (MU) for the usual intensity beam. But the main monitor reduced the accuracy in the TEPC measurement due to the considerable leak charge as compared with charge collection by the low-intensity beam. So, an alternative parallel-plate ionization chamber monitor (PPIC monitor; diameter: 220 mm, gap: 10 mm) was placed upstream of the main monitor to deal with the leaked current for the low-intensity beam. The leakage current of the PPIC monitor was reduced to less than 1.0 pA by the flow of dry air in the chamber. The practical leakage charge was calculated by multiplying the leakage current by the measurement time. We found that the percentage of the leakage charge was less than 1.2% in the TEPC measurement condition. The ratio of the net charge of the PPIC monitor and the main monitor unit (MU) was measured for the usual beam intensity before and after the TEPC measurement. The monitor ratio was almost constant within 0.4% by the repetitive measurements for various beam intensities from the usual beam intensity down to the thousandth intensity (2 × 10 6 particles/ pulse). The monitor ratio decreased and dispersed below the thousandth intensity with an increase in the measurement time, because the MU value was obviously influenced by the leakage current of the main monitor. Thus, the net charge of the PPIC monitor multiplied by the monitor ratio of the usual beam intensity was substituted for the MU value during the TEPC measurement.
The absorbed dose, Dabs, in water for beam quality Q was obtained using the TEPC calibrated with the 60 Co gamma rays, Q0, as follows: 21) ,
where (swater,gas)Q is the mass stopping power ratio of water to the tissue-equivalent gas for beam quality Q, (wgas)Q is the mean energy required to form an ion pair in tissue-equivalent gas for beam quality Q, and PQ is the perturbation correction factor of the beam quality Q. The PQ value was assumed to be 1.00, because that for the carbon-ion beam was unspecified. The w values in p-TEG of 27.0 ± 0.3 eV for electrons and of 28.0 ± 0.5 eV for alpha particles (~5 MeV) were adopted for the (wgas)Q0 and (wgas)Q values, respectively.
29)
The (swater,gas)Q value of 0.999 ± 0.005 was used with reference to those for carbon-ion beams from 1 to 1000 MeV/u.
30)
A Markus PPIC (Type 23343, PTW-Freiburg) was also used to measure the absorbed dose in water for carbon-ion beams for comparison with the TEPC. The PPIC was calibrated according to the IAEA TRS-398 protocol 21) with the w value in air of 34.50 eV for heavy ions. Different w values were used for p-TEG in the TEPC and air in the Markus chamber, because the w values largely differ with gas type. Ideally, different w values should be used for different particles, but reports of the accurate w values for high-energy ions are limited at present, so we assumed that the w value was constant from proton to carbon-ion. The combined 3.2% uncertainty was recommended for the Markus chamber for heavy ions. 21 ) Fig. 1 . Schematic layout of the irradiation system of therapeutic carbon-ion beams when the TEPC measurement was performed in the horizontal beam course in the treatment room. The diameter of the flat irradiation field was set to 10 cm at the isocenter. The multileaf collimator of 140 mm in iron thickness was set to be fully opened to 22 cm × 15 cm. 
Derivation of the biological and clinical doses from the TEPC measurement
The biological and clinical doses are redefined after the NIRS-defined biological and clinical doses, 9) respectively, by using the microdosimetric quantities in the way hereinafter prescribed.
The surviving curve, S, of HSG cells was calculated from the microdosimetric spectrum by the modified MKM with the model parameters of the HSG cells (α 0 = 0.13 Gy -1 , β = 0.05 Gy -2 , r d = 0.42 μm, and y 0 = 150 keV/μm) as follows: 16) ,
,
where ρ is the density of tissue assumed to be ρ = 1 g/cm 3 , f(y) is the probability density of lineal energy, y, y* is the saturation-corrected dose-mean lineal energy, and β is the constant value of 0.05 Gy -2 assumed to be independent by the LET. Then, the biological RBE of the HSG cells was calculated as follows:
where D10 is the 10% survival dose of in-vitro HSG cells for radiation of interest, and D10,R is the 10% survival dose of reference radiation, D10,R = 5.0 Gy, which was obtained from the empirical survival curve of the HSG cells irradiated by 200 kVp X-rays. 16 ) Then, the biological dose, Dbio, for HSG cells is defined as follows: ,
where the unit of Gy equivalent, GyE, was used for the Dbio value when the unit of Gy was used for the Dabs value. The clinical RBE was defined as the biological RBE multiplied by the clinical factor, k. Therefore, the clinical RBE, RBEclin, and the clinical dose, Dclin, were calculated as follows:
, (
where the unit of Gy equivalent, GyE, was used for the Dclin value when the unit of Gy was used for the Dabs value. The clinical factor, k = 1.43, was introduced to preserve the equivalent dose scale of the historical fast neutron radiotherapy at NIRS, 31) and it was the mean value of the clinical factors calculated for the typical treatment beams in the TPS at NIRS. The numerical validity of the clinical factor has not been clinically examined, so its optimum value and accuracy leave much room for discussion.
Note that the RBE clin and D clin values are available only for the early effect of therapeutic carbon-ion beams, because these are deeply connected to single-cell survival. We did not consider late effect or small dose exposure in this study. We think the choice of 10% survival RBE of HSG cells is reasonable as a typical dose per clinical fraction in the normal carbon-ion therapy, which ranges from 2.9 to 8.0 GyE/ fraction except for the hypofraction radiotherapy.
3)
RESULTS
Absorbed dose and y* value
The numerical results such as the D abs and y* were calculated from the measured spectra. The bin sizes of energy imparted were 3.0, 45, and 671 eV for high-, middle-, and low-gain spectra, respectively. The lowest levels of energy imparted were 15 eV, 4.4 keV, and 67 keV for high-, middle-, and low-gain spectra, respectively. Dead times were suppressed to 1% or less, and the scaling factor of event numbers was assumed to be unity. The overlap regions of lowergain spectra were not used for analysis, and each joint between high and medium gains or medium and low gains was calculated as if there was one joint channel of a specific binning width to maintain the total count number. Table 1 S The systematical uncertainty in the water-equivalent depth was thought to be 1.5 mm in consideration of the spherical wall and placement accuracy of the TEPC. The combined uncertainty in the D abs value measured by the TEPC was calculated from the systematical uncertainty of 4.8% and the statistical uncertainty of the measured spectra. The combined uncertainty in the y* value was also calculated from the systematical uncertainty of 3.6% and the statistical uncertainty. The assumptive sources of the uncertainties are the NX value (0.7%), the value (0.5%), 21) the 600-ml ionization chamber reading (0.1%), the Awall value, the βwall value and the Km values (2%), the standard deviation of (2%), the dead time (1%) and lower cut-off (1.4%),
the PQ value (1%) and (swater,gas)Q value (2%), the w values for electrons (1.1%) and alpha particles (1.8%), 29) and the monitor ratio (1%).
Microdosimetric spectra
The dose spectrum yd(y) against y in the semi-log representation is the standard representation of a microdosimetric spectrum. The integrals of the d(y) spectra were normalized to unity. Figure 2 shows the typical yd(y) spectra measured by the same type of the two TEPCs for the 60 Co gamma rays and the 290 MeV/u carbon-ion beam with a 6-cm SOBP at four depths of the entrance, the proximal SOBP, the distal SOBP, and the fragmentation tail. We confirmed that the two TEPCs produced almost the same spectra because of the calibration with the 60 Co gamma rays. The differences of the D abs , y* and D clin values between the two TEPCs were smaller than these uncertainties, while the mean energy imparted by alpha particles of each internal source had differed by 13%. The carbon-ion events mainly ranged from 10 to 1000 keV/μm, while the gamma ray events ranged from 0.1 to 10 keV/μm. The yd(y) spectra dispersed and shifted to higher y events with the depth up to the SOBP distal peak because of the increase of the LET and the accumulation of the energy straggling and multiple scattering for carbon ions. The relativistic carbon ion can undergo a nuclear fragment reaction in material.
32) The nuclear fragments produced from primary carbon ions by striking atomic nuclei in target materials are lighter ions between protons and boron ions. Maximum kinetic energy per nucleon of fragment particles is approximately equal to that of the primary ion just before the nuclear collision. At the isocenter of the therapeutic 290 MeV/u carbon-ion beam with 6-cm SOBP, the energy ranges of carbon ions were calculated to be up to about 110 MeV/u, and the contribution of nuclear fragments to the absorbed dose was estimated to be about 17%. The fragment particles generated from the carbon-ion can proceed beyond the maximum range of the carbon ion. The spectrum beyond the SOBP distal peak mainly consists of the lighter ions produced by the fragment reactions. Figure 3 shows the absorbed dose distributions of the 290 MeV/u carbon-ion beams with 6-cm SOBP. The absorbed doses measured by the TEPC were nearly consistent with those measured by the Markus PPIC within the combined uncertainties. The absorbed dose distribution calculated in the TPS was normalized at the central depth of the SOBP as in the treatment. Figure 4 shows the comparison of the biological RBE distributions between the TEPC and the calculation in the TPS. For the 290 MeV/u beam, the biological RBE values obtained by the TEPC agreed well with those calculated by the TPS within the uncertainties, except in the fragmentation tail. Figure 5 shows the absolute depth-dose distributions of the Dbio and Dclin values for the 290 MeV/u carbon-ion beams with 6-cm SOBP. The combined uncertainties in the Dbio and Dclin values were calculated from the uncertainties in the Dabs value and the y* value. The Dbio value obtained by the TEPC decreased with the depth in the SOBP region, while the biological dose was designed to be constant in the TPS. The experimental Dbio value of the HSG cells also shows the same decreasing tendency.
Depth-dose distributions
For example, at the rear SOBP depth of 136 mm, the Dbio value derived by the TEPC was 8% lower than the calculated biological dose in the TPS. The 8% reduction was attributed to the 6% decline of the D abs value and the 2% decline of the RBE 10 value. The 6% decline of the D abs value means the difference between 5.649 × 10 -5 Gy/MU for the TEPC measurement and 6.02 × 10 -5 Gy/MU for the calculation at the depth of 136 mm, though the TEPC measurement had the margin of uncertainty of 5.3%. The 2% deviation of the RBE 10 value was too small to discuss in detail because there would be many potential sources of systematic errors such as change in the β value, determination error of the MKM parameters, the wall effect of TEPC and so on. However, the variation of the RBE10 value intended to expand the variation of the Dbio value. Therefore, not only the absorbed dose but also the RBE value or radiation quality should be considered as part of the quality assurance for carbon-ion beams. 
DISCUSSION
Uncertainty in the TEPC measurement
Wall effect is an indispensable problem in using the walled TEPC. Nikjoo et al. investigated the wall effect using Monte Carlo track structure calculations, and revealed that y D values measured by walled TEPC became significantly larger than those measured by wall-less TEPC for energetic heavy ions mainly due to entry of secondary electrons created in the wall of the walled TEPC. 33, 34) In principle, the wall-less TEPC should be used to measure the y spectrum for RBE estimation by the MKM calculation because the MKM was based on energy imparted to microscopic domain in homogeneous medium. However, the wall-less TEPC was impractical for measuring treatment beams in water phantom due to several inconvenient profiles such as counter size and output instability. In addition, the MKM parameters used in this study had been determined from y spectra measured by the walled TEPC, and the walled TEPC were also used for measuring the y spectra to obtain the biological dose. Thus, the wall effect in the both experimental data would cancel out each other, and would not cause significant effect in the RBE estimation based on the MKM. In the future plan, the influence of wall effect on the MKM parameters, the estimated RBE and the absorbed dose will be analyzed by the computer simulation in order to evaluate accurate uncertainties in the biological dose.
Diffecrence between the TEPC measurement and the TPS calculation
The differences of the RBE value and biological dose around the fragment tail and the distal SOBP region between the TEPC and the TPS had been indicated by Monte-Carlo simulations. 35, 36) The principal reason for the differences was that the one-dimensional calculation of the TPS did not take into account the spatial escapes of particles from the beam axis due to beam divergence, beam scattering and nuclear fragmentation in the air, scatterer, ridge filter, and water phantom.
We also examined the slight difference in absorbed dose between the TEPC and the Markus PPIC. Figure 6 shows the absorbed dose ratio measured by the TEPC relative to the PPIC. We found that the Dabs values obtained by the TEPC were, on average, a few percent larger than those measured by the PPIC for high-energy carbon-ion beams, except in the back of the carbon-ion range. The differences in the measured Dabs values can be explained by the shift of the w value in air and p-TEG. The w value in air for high-energy carbonion beams was recently reported to be 35.72 eV measured by the graphite calorimeter, 37) which was 3.5% larger than the 34.50 eV in w value recommended for heavy-ion dosimetry. 21) The depth dependence of the absorbed dose ratio of the TEPC to the PPIC is thought to be caused by the energy dependence on the wall effect, w value, mass stopping power ratio, and perturbation factor. If those dependences become apparent for heavy ions, then the spectral dosimetry with the TEPC would correct the quality factor with respect to each event, which could contribute to obtaining a more appropriate dose in water than the integral dosimetry such as that obtained in an ionization chamber.
In this study, the biological dose was specified to be a measurable quantity based upon MKM parameters that had only been correlated with cell survival experiments under controlled conditions. We excluded discussion of the biological application of the modified MKM and instead focused on the physical quantities and uncertainties of the TEPC measurement. Actually, the 10% survival dose of HSG cells for the reference X-rays, D 10,R = 5.0 Gy is larger than the previous value of 4.08 Gy reported by Furusawa et al. 38) This difference in the D 10,R value is thought to be caused by the change of cellular radio-sensitivity, experimental condition, serum component in the nutrient medium, and so on. Though the D 10,R value changed by about 20%, the RBE 10 values estimated from the TEPC measurement were not so different with the TPS calculation except for the fragment tail, as shown in Fig. 4 . Therefore, we think that the difference in the D 10,R value has an insignificant effect on the biological dose, if the survival curves to derive the RBE values were measured under the same condition.
Hereafter, the verification of RBE from clinical perspectives will be a very important subject of inquiry for particle beam therapy. The TEPC measurement would provide useful information for analyzing the clinical results based on the radiation qualities. However, the uncertainty in the biological dose measured by the TEPC was too large to put the TEPC measurement into practical use for quality assurance in carbon-ion radiotherapy. Therefore, further reduction of the uncertainties is an issue that must be addressed.
